Shanghai Launches China's First TCM IP Rights Transfer Platform
This article was originally published in PharmAsia News
Executive Summary
Shanghai Pudong Intellectual Property Center recently launched China's first IP rights transfer platform for TCM to pave the way for TCM research commercialization. A total of 140 enterprises and institutions, of which 80 are from Shanghai, have joined the initiative. Members can access the platform's website and use patent information search and analysis, project supply-and-demand intelligence, as well as TCM patent market evaluation. Although the platform builds on the foundation of State Intellectual Property Office's patent database, it provides specialized search functions such as identification of keywords with TCM characteristics. However, officers in charge admitted that the current supply and demand is unbalanced due to relatively few TCM innovative achievements. (Click here for more - Chinese language)